Glucagon-like peptide 1 (GLP-1) analogs are injectable drugs used to treat type 2 diabetes. They work by stimulating the release of insulin from the pancreas, suppressing glucagon secretion, and slowing gastric emptying which leads to a reduction in post-prandial glycemia. GLP-1 analogs such as Exenatide and Liraglutide are prescribed as an adjunct to diet and exercise to improve glycemic...
0 Commentarios
0 Acciones
1252 Views
0 Vista previa